Where is Dominion Biotech located?

Dominion Biotech is headquartered in Manchester, United Kingdom.

Where does Dominion Biotech rank among its competitors?

Dominion Biotech ranks 6th amongst 12 active competitors, only 1 of which is funded., of which only Oncosyne is funded and secured an undisclosed amount in Jan, 2024.

Who are the top competitors of Dominion Biotech?

Dominion Biotech's top competitors include Redbud Medicine, L2P Research and AlphaVax. Among them, Oncosyne secured the most recent funding round in January, 2024.

Dominion Biotech - 2026 Company Profile & Competitors

Dominion Biotech is an unfunded company based in Manchester (United Kingdom). It operates as a Provider of patient-derived cell models and assays for cancer drug discovery. Dominion Biotech has not raised any funding yet. The company has 12 active competitors, including 1 funded and 1 that has exited. Its top competitors include companies like Redbud Medicine, L2P Research and AlphaVax.

Company Details

Provider of patient-derived cell models and assays for cancer drug discovery. It offers drug screening, 3D tumoroid models, and immunotherapy testing using autologous peripheral blood mononuclear cells. The company develops patient-derived cell models through tissue supplier partnerships and genetic characterization using next-generation sequencing. It provides assay development, validation, data analysis, and reporting services, including advanced statistical analysis and integration of genomic and clinical data.

Key Metrics

Location

Manchester, United Kingdom

Stage

Unfunded

Ranked

6^th among 12 active competitors

Similar Companies

Redbud Medicine & 13 more

View Dominion Biotech's full profile

Dominion Biotech has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dominion Biotech include Redbud Medicine, L2P Research and AlphaVax. Here is the list of Top 10 competitors of Dominion Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Redbud Medicine 2019, Beijing (China), Deadpooled	Provider of regulatory affairs, R&D, data management and statistical analysis services	$10M	Delian Capital, Juming Venture Capital	34/100
2nd	L2P Research 2015, Stony Brook (United States), Acquired	Preclinical research organization specializing in oncology animal models and offering a wide range of research services	-	Long Island High Technology Incubator, HHS	31/100
3rd	AlphaVax 1997, Durham (United States), Funding Raised	RNA particle vaccine technology company developing anti-infective and anti-cancer vaccines	-	Springboard Enterprises, Military Health & 1 others	25/100
4th	Oncosyne 2020, Oslo (Norway), Seed	CRO focused on in vitro diagnostics clinical-grade cancer drug screening services	-	StartupLab, Fortress Fund & 1 others	22/100
5th	Lukas Biomedical 2017, Taiwan, Unfunded	Biotechnology company developing autologous immune cell therapy to treat various types of cancer	-	-	19/100
6th	Dominion Biotech Manchester (United Kingdom), Unfunded	Provider of patient-derived cell models and assays for cancer drug discovery	-	-	19/100
7th	Anemos Bio 2026, Unfunded	Developer of patient derived lung cancer cell lines for research	-	-	19/100
8th	DXOCRO 2017, Oxford (United States), Unfunded	CRO offering in-vitro preclinical services for the development of oncology drugs	-	-	18/100
9th	Cancer Research For Oza Rks 1987, Springfield (United States), Funding Raised	CRO focused on providing clinical trials and research services for oncology drugs	-	HHS	16/100
10th	CRISPR Cures for Cancer 2023, United States, Unfunded	Provider of cancer therapeutics design and development services	-	-	16/100